
Pfizer says Canada just approved its new COVID-19 vaccine for this fall
Global News
Pfizer said Health Canada has approved its latest COVID-19 vaccine that targets a new Omicron variant. It will be made available in the fall.
Pfizer’s latest vaccine against the current variant of COVID-19 is set to be available this fall in Canada, the company announced on Tuesday.
In a news release, Pfizer Canada and BioNTech said that Health Canada authorized the LP.8.1 variant COVID-19 vaccine for individuals six months and older.
The updated vaccine targets the Omicron LP.8.1 variant of COVID-19.
The company said the vaccine will be available in most pharmacies across the country in the fall, noting each province has different eligibility criteria for its public vaccination program.
Provincial and territorial health authorities will share more details about rollouts.
Most provinces and territories in Canada do not charge Canadians for the COVID-19 vaccine, however Alberta recently changed its own strategy, requiring residents who want it this year to pre-order the shot and pay for it out of their own pocket.
The cost is not yet known.
The change took effect last week but was first announced in June after the federal government put the provinces in charge of buying COVID-19 vaccines, as is routine with other immunization programs.













